New brunswick

Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group

Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer’s Immunotherapy Program and Equity Investment

NEW BRUNSWICK, New Jersey - In a joint statement, Czura Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to augment our Life Sciences Group with Clearstone Central Laboratories and the deep expertise of the people there.

MORE..

Older News

NEW BRUNSWICK, New Jersey and DUBLIN - - First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline - Johnson & Johnson Equity Investment Provides Financial Flexibility for Elan Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson & Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP Program), through a newly formed company.

MORE..